Since 2011, Robert Ivy has been the CEO and Executive Vice President of the prestigious American Institute of Architects. Ivy holds a Masters of Architecture Degree from Tulane University, along with a Bachelor of Arts Degree in English from The University of the South: Sewanee. His education and career accomplishments in the field of architecture are astounding.
Ivy had been the Editor in Chief of the world renowned Architectural Record since 1996. Robert Ivy is usually credited with the explosive growth of this popular architectural journal. He became both the Vice President and the Editorial Director the the famed Mcgraw-Hill Construction Media. This company includes the highly-regarded Magazine of Sustainable Design: GreenSource, China, SNAP, HQ Magazine and the Architectural Record.
Follow Robert Ivy on Twitter
Ivy was honored to be a juror on a panel that ultimately named architect Frank Gehry the choice to build The Dwight D. Eisenhower Memorial. Robert Ivy served as president of Dean/Ivy and Dean/Dale in the years 1981 to 1996. During this time, Ivy worked as a critic for a number of nationally read publications.
The Architectural Journal received several coveted publishing awards while Ivy was Editor in Chief. This included the National Magazine Award for General Excellence, a rare feat for a professional magazine to accomplish. This journal also won 7 Ozzie awards, 26 Jessie H. Neal Awards and in 2008, the magazine took home the MPA Digital Award for its website that year. Ivy holds numerous personal awards, including the Crain Award. He has been recognized for his superior management skills and was named a “Master Architect” by the National Architect Fraternity: Alpha Rho Chi. The fraternity was impressed with how effectively Robert Ivy was in his ability to communicate the monumental value of design. This high award has only been given to seven architects since the fraternity was founded 100 years ago. Ivy is the only architect given this award in this century.
Robert Ivy has a published biography of Frank Lloyd Wright’s apprentice. Written in 2001, Ivy’s book, “Fay Jones: Architect,” is in its third edition. Ivy was born in Columbus, Mississippi and he currently lives in Washington, DC. Ivy remains the EVP/CEO of the American Institute of Architects. Robert Ivy has been a leader in the architectural world for decades. Robert Ivy continues to influence architectural visions. Today’s architects owe thanks to Ivy for putting architecture in the media spotlight.
Dr. Jeanmarie Guenot, Ph.D., is a leader in the cancer research community. She has dedicated her career to irradicating cancer through the use of innovative drug therapies. She has years of experience as both a researcher as well as a business leader. She earned her Ph.D. at the University of California, San Francisco and her MBA at the Unversity of Pennsylvania – The Wharton School.
Dr. Jeanmarie Guenot started her career as a Principal Scientist at Hoffman-La Roche where she performed research and development into cancer drug therapies. She became an executive level leader in 2003 at PDL Biopharma where she was the Vice President of Corporate and Business Development. Since then she has also founded two companies; Guenot, LLC and SKS Ocular, LLC and served both companies as their Managing Partner. She was also the President and Chief Executive Officer of Amphivena Therapeutics, Inc., a San Francisco-based company that is engaged in developing drugs to fight cancer. At Amphivena Therapeutics, Dr. Jeanmarie Guenot was focused on developing bifunctional antibody therapies which are designed to treat different forms of blood-borne cancer.
Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies
Dr. Guenot is now the Chief Executive Officer of another San Francisco biotechnology company, Maverick Therapeutics, Inc. Dr. Guenot has explained that a lot of drugs that treat cancer also destroy so much nearby tissue that in the end, the patient has gained little. She ends to change this state of affairs with a drug under development at Maverick Therapeutics on Crunchbase. The way her cancer drug will do this is by using the patient’s own T cells to fight cancer. T cells are white blood cells that are a necessary part of the body’s reaction to foreign invaders and make up a person’s immune system. Dr. Guenot said that her company will have a drug out within the next five years which will be able to cleanly kill cancer and not destroy other, healthy nearby tissue.
Under Dr. Guenot’s leadership, Maverick Therapeutics has raised $125 million in funding from Takeda Pharmaceutical Co. Ltd, headquartered in Japan, and the venture capitalist firm MPM Capital.
Learn more about Jeanmarie Guenot: http://www.guenotllc.com/Biography.html
The Meriwether Group offers funding, acceleration, and exit strategy support for startups and businesses looking to grow. It funds companies with equity or debt. A team of 12 talented people brings its collective experience and business understanding to help entrepreneurs realize business success. The company sees entrepreneurs as modern day heroes. These are the people who make a major impact on society by the products and services they create.
David Howitt is the founder of the Meriwether Group. He and his wife Heather have two children: Sawyer Howitt and Hailey. These two are fortunate to have a talented father who can help pave the way for their success in life. Visit This Page.